FNY Investment Advisers’s Medpace MEDP Stock Holding History

FNY Investment Advisers’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,000	Closed	-$59K	–	885
2018 Q3	$59K	Buy	+1,000	New	+$54.7K	0.01%	346

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

FNY Investment Advisers's MEDP Position: Q4 2018 in Review

FNY Investment Advisers sold out of Medpace (MEDP) in Q4 2018, closing a stake of 1,000 shares — an estimated $59K sold.

FNY Investment Advisers first reported a position in MEDP in Q3 2018 and held it in 1 quarter. The position peaked at $59K in Q3 2018. 216 funds tracked by Wall St. Rank hold MEDP as of Q4 2018.

FNY Investment Advisers reported no remaining Medpace position as of Q4 2018 after selling out during the quarter.
FNY Investment Advisers sold 1,000 Medpace shares in Q4 2018, an estimated $59K.
FNY Investment Advisers first reported a position in Medpace in Q3 2018 and held it in 1 quarter.
FNY Investment Advisers's Medpace position peaked at $59K in Q3 2018.
216 funds tracked by Wall St. Rank held Medpace as of Q4 2018.

Based on FNY Investment Advisers's 13F filing for Q4 2018, filed 22 Jan 2019.